Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 12.8.2026AS GRINDEKS (ASK)3229ESitagliptin/Metformin Grindeks 50 mg/1000 mg filmom obalené tablety (tbl flm 196(2x98)x50 mg/1000 mg (blis.PVC/PVDC/Al-multibal.))1.2.2026Z
 12.8.2026Teva B.V. (TEV-NL-4)51633Valsartan Teva 80 mg (tbl flm 28x80 mg (blis.PVC/PE/PVDC/Al))15.9.2026R
 12.8.2026Teva B.V. (TEV-NL-4)51647Valsartan Teva 160 mg (tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al))15.9.2026R
 12.8.2026TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)21278Atorvastatin Teva Pharma 20 mg (tbl flm 90x20 mg (blis.Al/Al))24.9.2026Z
 12.8.2026Novartis Slovakia s.r.o. (NVL-2)84047Sandimmun Neoral 100 mg/ml (sol por 1x50 ml/5 g (fľ.skl.hnedá))12.8.2026O
 12.8.2026Teva B.V. (TEV-NL-4)0055FGabapentin Teva B.V. 100 mg (cps dur 100x100 mg (blis.PVC/PVdC//Al))27.8.2026R
 12.8.2026ratiopharm GmbH (RAT)6548BEporatio 30000 IU/1,0 ml injekčný roztok v naplnenej injekčnej striekačke (sol inj 6x1,0 ml/30000 IU ( striek.skl.napl. s bezpeč.ihlou))15.9.2026R
 12.8.2026Egis Pharmaceuticals PLC (EGI)0258CZitazonium 20 mg (tbl 100x20 mg (blis.OPA/Al/PVC/Al))11.8.2026O
 12.8.2026Samsung Bioepis NL B.V. (SUO-NL)6118EPyzchiva 90 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x1 ml/90 mg (striek.inj.napl.skl.))5.8.2026O
 12.8.2026Sandoz GmbH (SAN-A)65482Zarzio 30 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke (sol ijf 1x0,5 ml/30 MU (striek.inj.skl.napln. s ochr.krytom ihly))15.8.2026R
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28912Ospamox 750 mg filmom obalené tablety (tbl flm 14x750 mg (blis.PVC/PVDC/Al))15.8.2026Z
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)52089Mykofenolát mofetil Sandoz 500 mg filmom obalené tablety (tbl flm 50x500 mg (blis.PVC/PE/PVDC/Al))15.8.2026R
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)52466Fludarabin Sandoz 25 mg/ml koncentrát na injekčný/infúzny roztok (con ijf 1x2 ml/50 mg (liek.inj.skl.))15.8.2026R
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)12663Doxorubicin Sandoz 2 mg/ml (sol ijf 1x5 ml/10 mg (liek.inj.skl.))10.8.2026O
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9827CDasatinib Sandoz 70 mg (tbl flm 60x1x70 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.))10.8.2026O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)